Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Queensland Health
Moodys
Fuji
QuintilesIMS
UBS
Deloitte
Cantor Fitzgerald

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020367

« Back to Dashboard

NDA 020367 describes CEREZYME, which is a drug marketed by Genzyme and is included in one NDA. It is available from one supplier. Additional details are available on the CEREZYME profile page.

The generic ingredient in CEREZYME is imiglucerase. One supplier is listed for this compound. Additional details are available on the imiglucerase profile page.
Summary for 020367
Tradename:CEREZYME
Applicant:Genzyme
Ingredient:imiglucerase
Patents:0
Therapeutic Class:Enzyme Replacements/Modifiers
Pharmacology for NDA: 020367
Ingredient-typeGlucosylceramidase
Suppliers and Packaging for NDA: 020367
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEREZYME imiglucerase INJECTABLE;INJECTION 020367 NDA Genzyme Corporation 58468-1983 N 58468-1983-1
CEREZYME imiglucerase INJECTABLE;INJECTION 020367 NDA Genzyme Corporation 58468-4663 N 58468-4663-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength200 UNITS/VIAL
Approval Date:May 23, 1994TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength400 UNITS/VIAL
Approval Date:Sep 22, 1999TE:RLD:Yes

Expired US Patents for NDA 020367

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-002 Sep 22, 1999 ➤ Sign Up ➤ Sign Up
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-001 May 23, 1994 ➤ Sign Up ➤ Sign Up
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-002 Sep 22, 1999 ➤ Sign Up ➤ Sign Up
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367-001 May 23, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Argus Health
Cantor Fitzgerald
Cipla
Merck
Medtronic
Moodys
Colorcon
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.